Genmab | GEN - Loan Capital


Genmab reported DKK4.96B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 303.77M 21.04M Jun/2026
Amgen USD 51.86B 27M Jun/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 31.16B 480M Jun/2026
BioMarin Pharmaceutical USD 3.53B 2.1B Jun/2026
Demant DKK 13.13B 5.86B Jun/2026
Fresenius Medical Care EUR 5.82B 83.04M Jun/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GN Store Nord DKK 8.11B 4M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Insmed USD 543.51M 1.3M Jun/2026
Lakefront Biotherapeutics EUR 4.77M 78K Jun/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 11.21B 406M Jun/2026
Novartis USD 37.49B 42M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
UCB EUR 2.18B 634M Dec/2025